PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing

July 25, 2024

https://www.globenewswire.com/news-release/2024/07/24/2918015/0/en/PainReform-Files-Patent-Covering-Highly-Scalable-Manufacturing-Process-for-PRF-110-Following-Successful-Completion-and-Testing.html

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq:PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it has filed a patent covering its new and highly scalable manufacturing process for PRF-110, its flagship product designed to revolutionize post-operative pain control. The patent filing follows successful completion and testing of the new process. This milestone not only marks a critical step forward in preparation for future potential market launch of PRF-110, allowing a smooth step-wise increase of batch manufacturing, but also underscores the Company’s commitment to enhancing manufacturing efficiency and reducing costs.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.